Company intelligence / Profile preview

Enspectra Health

Mountain View, California, United Statesenspectrahealth.com ↗

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

Enspectra Health’s VIO System has received FDA clearance as the first multiphoton imaging modality for noninvasive real-time visualization of skin at cellular resolution. In pivotal multicenter studies, physicians identified key skin features on VIO images with over 90% accuracy. The company also received FDA Breakthrough Device Designation in June 2024 for its next-generation AI-powered platform targeting early detection of non-melanoma skin cancers in high-risk populations.

Therapeutic areas: OncologyDermatology
Modalities: DeviceNon-pharmacological therapy (virtual biopsy/imaging)AI/ML-powered diagnostic platform
Industry: Pathology

Drug pipeline

1 asset

VIO System

Commercial

Indications: Skin tissue assessment, Nonmelanoma skin cancer

Partnerships

Collaborations with select clinical partnersRelationship with Fogarty Institute for Innovation provides access to R&D/manufacturing resources

Beyond the preview

Go deeper on Enspectra Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enspectra Health.

Explore the full profile